NCT04695301

Functional Outcomes in COVID-19 Survivors and Use of a Digital Platform for Rehabilitation

Completed NA Last updated 11 February 2022

What this trial tests

NA trial testing Rehabilitation protocol through a digital platform in COVID-19 in 25 participants. Completed in 1 October 2021.

Timeline

1 July 2020

Primary endpoint
1 July 2021

1 October 2021

Quick facts

Lead sponsor	Hospital Israelita Albert Einstein
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	crossover
Masking	single
Primary purpose	other
Enrollment	25
Start date	1 July 2020
Primary completion	1 July 2021
Estimated completion	1 October 2021
Sites	1 location across Brazil

Drugs / interventions tested

• Rehabilitation protocol through a digital platform

Conditions studied

• COVID-19 — all drugs for COVID-19 →
• Coronavirus Infections — all drugs for Coronavirus Infections →
• Exercise Therapy — all drugs for Exercise Therapy →

Sponsor

Hospital Israelita Albert Einstein

Who can join

Adults 18 to 80, any sex, with COVID-19 or Coronavirus Infections. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

COVID-19, an acute respiratory disease caused by coronavirus-2 (SARS-CoV-2), and in most cases, causes mild to moderate symptoms of fever, cough and dyspnea. However, a not insignificant portion, given the total number of people affected, will present symptoms of severe acute respiratory failure and multiple organ failure, requiring hospitalization under intensive care, use of mechanical ventilation, prolonged period of immobilization and, consequently, physical, cognitive and psychological damage, which may affect survivors for a long period after hospitalization. All of these factors are known to have an impact on various areas of life: personal, social and economic, which makes the need for continued specific care after hospital discharge relevant. In this context, the role of rehabilitation programs is fundamental, aiming not only at a safer dehospitalization, but also at the continuity of care with the objective of restoring the biopsychosocial skills of these individuals, allowing functional independence for activities of daily life and a shorter return physical and social activities performed before the disease. However, the big challenge for the health system is how to offer this on a large scale. Therefore, knowing the clinical and functional profile of these patients at discharge and verifying the viability of a digital platform for rehabilitation and monitoring of these patients is the first step to allow the creation of a new form of continuity of care and access to affected patients with serious diseases such as COVID-19 and other syndromes capable of generate functional impairment. Therefore,the investigators objective is to characterize and monitor the functional profile and exercise capacity of patients affected by COVID-19 at the hospital discharge, as well as to verify the viability and compliance of patients to the use of a digital platform for the application of a distance rehabilitation program.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.